NCT02557308View on ClinicalTrials.gov

An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis

TerminatedOBSERVATIONAL
Enrollment

329

Participants

Timeline

Start Date

May 26, 2015

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
Ankylosing Spondylitis
Sponsors

Lead Sponsor

Celltrion
All Listed Sponsors
lead

Celltrion

INDUSTRY